This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Belboul, A. Articles by Al-Khaja, N. Search for Related Content PubMed PubMed Citation Articles by Belboul, A. Articles by Al-Khaja, N. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Blood Thinners Hazardous Substances DB HEPARIN Social Bookmarking                         What's this?

Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery

Department of Thoracic and Cardiovascular Surgery, University of Gothenbourg, Sahlgrenska Hospital, Goteborg

Najib Al-Khaja

Department of Thoracic and Cardiovascular Surgery, University of Gothenbourg, Sahlgrenska Hospital, Goteborg

To evaluate whether the effect of heparin coating the extracorporeal circuit resulted in differences in patient outcome and haemostatic alteration, 24 patients undergoing elective, isolated coronary artery bypass were randomized prospectively to cardiopulmonary bypass (CPB) with heparin-coated circuits (group H, n = 12) or uncoated circuits (group C, n = 12). The technique of CPB, heparinization and its reversal were the same in both groups. We studied complement status (C3d, C3, C3d/C3, C4 and C-function), white blood cell counts with differentiation and the postoperative morbidity. The results confirmed that CPB activates complement and increases neutrophils in both the H and C groups. A significantly lower level of Ieucocytosis was seen in group H compared to the C group (p < 0.05). The complement function via the classical pathway (C-function), expressed as a percentage of the function of a reference serum pool (the values of normal sera were 75-125%), was significantly reduced in both heparin-coated and uncoated circuits (p < 0.05). There was no significant intergroup difference regarding C3, C3d/C3, C4 and C-function during the study period. A lower frequency of postoperative morbidity was present in the H group. We conclude that heparin-coated surfaces elicit less leucocytosis and decrease postoperative morbidity in patients undergoing cardiac surgery but do not cause a significant difference regarding activation of the complement system as reported by many other investigators.

Perfusion, Vol. 12, No. 6, 385-391 (1997)
DOI: 10.1177/026765919701200607


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Ranucci, A. Balduini, A. Ditta, A. Boncilli, and S. Brozzi A Systematic Review of Biocompatible Cardiopulmonary Bypass Circuits and Clinical Outcome Ann. Thorac. Surg., April 1, 2009; 87(4): 1311 - 1319. [Abstract] [Full Text] [PDF]

				R Miraziz, L Hines, M Brouwer, R Steel, and P Klineberg Bridging circuit for the resection of retroperitoneal sarcoma involving the aorta and the IVC - veno-venous to veno-arterial perfusion Perfusion, January 1, 2008; 23(1): 65 - 69. [Abstract] [PDF]

				O. Mangoush, S. Purkayastha, S. Haj-Yahia, J. Kinross, M. Hayward, F. Bartolozzi, A. Darzi, and T. Athanasiou Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1058 - 1069. [Abstract] [Full Text] [PDF]

				H. P. Wendel, N. Hauser, F. Briquet, and G. Ziemer Hemocompatibility of Medical Connectors with Biopassive or Bioactive Surface Coatings J Biomater Appl, July 1, 2002; 17(1): 5 - 17. [Abstract] [PDF]

				H. A. Hennein Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255. [Abstract] [PDF]

				H. Suhara, Y. Sawa, M. Nishimura, H. Oshiyama, K. Yokoyama, N. Saito, and H. Matsuda Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model Ann. Thorac. Surg., May 1, 2001; 71(5): 1603 - 1608. [Abstract] [Full Text] [PDF]

				A. Belboul, C. Lofgren, C. Storm, and M. Jungbeck Heparin-coated circuits reduce occult myocardial damage during CPB: a randomized, single blind clinical trial Eur. J. Cardiothorac. Surg., May 1, 2000; 17(5): 580 - 586. [Abstract] [Full Text] [PDF]

				S. Svenmarker, E. Jansson, H. Stenlund, and K. G. Engstrom Red blood cell trauma during cardiopulmonary bypass: narrow pore filterability versus free haemoglobin Perfusion, January 1, 2000; 15(1): 33 - 40. [Abstract] [PDF]

				H. P. Wendel and G. Ziemer Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation Eur. J. Cardiothorac. Surg., September 1, 1999; 16(3): 342 - 350. [Abstract] [Full Text] [PDF]